The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives

Swerdlow, Russell H., Burns, Jeffrey M., Khan, Shaharyar M.·2014·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2013.09.010

Cited by (786)

Items 601–700 of 786

  1. Mitochondrial Manipulation and the Quest for Alzheimer's Treatments
    Russell Howard Swerdlow · 2015 · EBioMedicine
  2. Toxicology of neurodegenerative diseases
    Vasileios Siokas, Athina‐Maria Aloizou, Georgia Pateraki · 2021 · Elsevier eBooks
  3. The role of oxidative stress in the development of Alzheimer's disease
    Vladimir Nikolaevich Nikolenko, N. A. Rizaeva, Kirill Vladimirovich Bulygin, V. M. Anokhina, A.A. Bolotskaya · 2022 · Neurology neuropsychiatry Psychosomatics
  4. The effects of age, genotype and diet on hippocampal subfield iron dysregulation and Alzheimer's disease biomarkers in an ApoE mouse model
    Elisabeth Black, Abbey Rasch, Tyler Wimmer, Alivia Li, Amanda Geovana Pereira de Araújo, Steve Cieslak, Kevin S. Steed, Rajan Adhikari, Jonathan J. Wisco, BreAnna Hutchinson · 2023 · European Journal of Neuroscience
  5. Symptomatic Cognitive Enhancing Agents
    Jeffrey L. Cummings, K. Zhong · 2016 · Elsevier eBooks
  6. Caspase-dependent degradation of MDMx/MDM4 cell cycle regulatory protein in amyloid β-induced neuronal damage
    Daniel J. Colacurcio, Jacob W. Zyskind, Kelly L. Jordan‐Sciutto, Cagla Akay · 2015 · Neuroscience Letters
  7. Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk
    Lili Gao, Yan Zhang, Jinghua Deng, Wenbing Yu, Yunxia Yu · 2016 · Medical Science Monitor
  8. Mitochondrial Repair Effects of Oxygen Treatment on Alzheimer’s Disease Model Mice Revealed by Quantitative Proteomics
    Hao Wang, Xiaoyu Hong, Yong Wang · 2017 · Journal of Alzheimer s Disease
  9. A review on molecular neuropathology of Alzheimer s disease in association with aging
    Tutun Das Aka, Md. Mamun Or Rashid, Shujit Chandra Paul, Md. Abdul Halim · 2018 · Journal of Research in Pharmacy
  10. Human skeletal muscle mitochondrial pathways are impacted by a neuropathologic diagnosis of Alzheimer's disease
    Chelsea N. Johnson, Mara R. Evans, Anneka E. Blankenship, Casey S. John, Michaella J. Rekowski, Michael P. Washburn, Andy V. Phan, Cynthia M. Gouvion, Mohammad Haeri, Russell Howard Swerdlow et al. · 2025 · Neurobiology of Disease
  11. Amyloid β Peptide Modifies Membrane Architecture and Surface Electrostatic Properties of Human Red Blood Cells
    Galya Staneva, Vesela Yordanova, Avgustina Danailova, Ana-Mariya Marinovska, András Dér, Stefka Germanova Taneva · 2025 · International Journal of Molecular Sciences
  12. Improvement of age-related neurocognitive disorders by Ginkgo biloba extract: neuroprotection in focus
    Anne Eckert, Dan Georgescu, Erich Seifritz, Walter E. Müller · 2026 · International Journal of Psychiatry in Clinical Practice
  13. Extracellular tau oligomers exert neurocytotoxicity by triggering mitochondrial dysfunction
    Mingzhu Sun, Jingye Lin, Songze Li · 2026 · Journal of Alzheimer s Disease
  14. Potential Protection Against Parkinson’s Disease by Ergothioneine—Nature’s Multifactorial Neuroprotectant
    Teddy J. W. Tng, Irwin Kee-Mun Cheah, Barry B. Halliwell, Kah‐Leong Lim · 2026 · Antioxidants
  15. The multifaceted role of mitochondrial dysfunction in Alzheimer’s disease pathogenesis
    Rasoul Ebrahimi, Ida Mohammadi, Kiana Ghafourian, Shahryar Rajai Firouzabadi, Mobina Saleh, Samin Davoody, Ghazal Azad, Khadijeh Esmaeilpour · 2026 · Metabolic Brain Disease
  16. Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease
    Jyoti Pandey · 2023 · Springer eBooks
  17. MitoH3: Mitochondrial Haplogroup and Homoplasmic/Heteroplasmic Variant Calling Pipeline for Alzheimer’s Disease Sequencing Project
    Congcong Zhu, Tong Tong, John J. Farrell, Eden R. Martin, William S. Bush, Margaret Ann Pericak‐Vance, Li‐San Wang, Gerard D. Schellenberg, Jonathan L. Haines, Kathryn L. Lunetta et al. · 2024 · Journal of Alzheimer s Disease Reports
  18. Unveiling mitochondria as central components driving cognitive decline in alzheimer's disease through cross-transcriptomic analysis of hippocampus and entorhinal cortex microarray datasets
    Pajaree Sonsungsan, Supatha Aimauthon, Nattawet Sriwichai, Poommaree Namchaiw · 2024 · Heliyon
  19. Analysis of Alzheimer’s disease associated deleterious non-synonymous single nucleotide polymorphisms and their impacts on protein structure and function by performing in-silico methods
    Betül Akçeşme, Nadia Islam, Delila Lekic, Raisa Ćutuk, Nejla Basovic · 2024 · Neurogenetics
  20. A polygenetic rat model of divergent aerobic capacity reveals a liver–brain interaction impacting Alzheimer's disease‐like phenotypes
    Colton R Lysaker, Benjamin A. Kugler, Vivien Csikós, Cole J. Birky, Caleb A. Gilmore, Madi Wenger, Edziu Franczak, Xin C. Davis, Brittany M Hauger, Julie Allen et al. · 2025 · The Journal of Physiology
  21. Comprehending Alzheimer's Disease: Molecular Mechanisms and Treatment Strategies
    Sunny Rathee, Vishal Pandey, Sakshi Soni, Debasis Sen, Sanjay Jain · 2025 · Current Alzheimer Research
  22. TOMM40 polymorphism is associated with resting-state functional MRI results in patients with Alzheimer’s disease
    Xuewen Xiao, Jingya Wei, Weiwei Zhang, Bin Jiao, Xinxin Liao, Chuzheng Pan, Xiaoyan Liu, Xinxiang Yan, Beisha Tang, Youming Zhang et al. · 2019 · Neuroreport
  23. Creatine monohydrate for mitochondrial nutrition
    Maher Abd EL-Nabi Kamel, Yousra Y. Moussa, Mennatallah A. Gowayed · 2022 · Elsevier eBooks
  24. Beyond cognition and sleep: Stop the domino effect
    Shaimaa Nasr Amin, Ahmed Sayed Khashaba, Ahmad Yousef Alazzam, Hamzeh Mahmoud ALKHAWALDAH, Khaled Anwer ALBAKRI, Omar Amjad ALMAJDOUBAH, Yasmeen Jamal Alabdallat, Ahmed Shaaban ABU SEIF · 2023 · Journal of Experimental and Clinical Medicine
  25. TOMM40 ‘523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOE ɛ3 Homozygotes
    Amber S. Watts, Stephen A. Haneline, Kathleen Anne Welsh-Bohmer, Jingtao Wu, Robert Alexander, Russell Howard Swerdlow, Daniel K. Burns, Ann M. Saunders · 2023 · Journal of Alzheimer s Disease
  26. Improvement of cognitive performance by a nutraceutical formulation: Underlying mechanisms revealed by laboratory studies
    Thomas B. Shea · 2021 · Free Radical Biology and Medicine
  27. The role of mitochondria-targeted antioxidant MitoQ in neurodegenerative disease
    Linlin Zhang, Aurelio Reyes, Xiangdong Wang · 2018 · Journal of Green Engineering
  28. A text mining application for linking functionally stressed-proteins to their post-translational modifications
    Oliver Bonham-Carter, Dhundy R. Bastola · 2015 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  29. ECSIT prevents Alzheimer’s disease pathology by regulating neuronal mitochondrial ROS and mitophagy
    Alice Lepelley, Lauren S. Vaughn, Agnieszka Staniszewski, Hong Zhang, Fang Du, Peter Koppensteiner, Zeljko Tomljanovic, Flávia Raquel Gonçalves Carneiro, Andrew F. Teich, Ipe Ninan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Effects of a Ketogenic and Low Fat Diet on the Human Metabolome, Microbiome and Food-ome in Adults at Risk for Alzheimer’s Disease
    Amanda Hazel Dilmore, Cameron Martino, Bryan J. Neth et al. · 2022 · medRxiv
  31. Editorial: Systemic implications of Alzheimer's disease
    Constanza J. Cortés, John P. Thyfault, Heather Wilkins · 2023 · Frontiers in Aging Neuroscience
  32. Mitochondrial Function and Neurodegenerative Diseases
    Wilkins, Heather M., Weidling, Ian, Koppel, Scott, Wang, Xiaowan, von Schulze, Alex, Swerdlow, Russell H. · 2018 · The Molecular and Cellular Basis of Neurodegenerative Diseases
  33. Enhancing mitochondrial functions in neuroinflammatory mouse model using isoflavones-loaded nanoparticles: A potential approach for Alzheimer's disease treatment
    Alaa A. Gad, Salma Nabil Tammam, Shaista Ilyas, Samar Mansour, Yomna A. Youssef, Karin S. Farag, Reham Mahmoud Abdel-Kader, Sanjay Mathur · 2024 · Journal of Drug Delivery Science and Technology
  34. Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice
    Duyan Geng, Aoge Liu, Yuxin Yan, Weiran Zheng · 2025 · Brain Research
  35. Repurposing the hypoglycaemic agents for neuroinflammation, a comprehensive review
    Vandana Blossom, Sheetal Dinkar Ullal, Rajalakshmi Rai, Melisha Michael D souza, P. Gopal Govind Kalluraya, Ayush Dixit, P. J. Jiji, Bukkambudhi Virupakshamurthy Murlimanju · 2025 · 3 Biotech
  36. Investigation into Efficacy and Mechanisms of Neuroprotection of Ashwagandha Root Extract and Water-Soluble Coenzyme Q10 in a Transgenic Mouse Model of Alzheimer’s Disease
    Caleb Vegh, Gabrielle Walach, Keanna Dube, Bromleigh Dobson, Rohan Talukdar, Darcy Wear, Hasana Jayawardena, Kaitlyn Dufault, Lauren Culmone, Subidsa Srikantha et al. · 2025 · Nutrients
  37. Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer’s disease dementia prognosis
    Jordi Gascón‐Bayarri, José Luis Mosquera, Marta Blanch, Pau Martí, Beatriz Fontal, Carla Trapero, Nuria Rojo, Inmaculada Rico, Jaume Campdelacreu, Cristopher Fowler et al. · 2025 · iScience
  38. A Perspective on the Role of Mitochondrial Biomolecular Condensates (mtBCs) in Neurodegenerative Diseases and Evolutionary Links to Bacterial BCs
    Matteo Calcagnile, Pietro Alifano, Fabrizio Damiano, Paola Pontieri, Luigi Del Giudice · 2025 · International Journal of Molecular Sciences
  39. Neuroprotection against beta-amyloid toxicity by the novel estrogen receptor modulator STX requires convergent signaling pathways
    Hunjoo Lee, Zoe Bostick, John Doherty, Tracy L. Swanson, Martin J. Kelly, Joseph F. Quinn, Nora E. Gray, Philip F. Copenhaver · 2025 · Frontiers in Molecular Neuroscience
  40. Imbalanced nutrition and increased dietary inflammatory index in children with autism spectrum disorder: associations with neurodevelopmental disorders
    Jing Shen, Junqiao You, Wenjing Wang, Wenli Yang, Wenli Zhao, Jianan Zhao, Huini Ding, Yuandi Xi, Hongmei Huang · 2025 · Frontiers in Nutrition
  41. Emerging role of cell membrane-coated nanoparticles in targeted therapy for brain disorders
    Vaishnavi Kumari, Mohd Shahrukh, Kahkashan Jabin, Nadiya Ali, Nazeer Hasan, Mohd. Aqil, Farhan Jalees Ahmad · 2026 · Biomaterials Advances
  42. Mechanistic insights into the synaptic damage-repair and regeneration processes in neurodegenerative Alzheimer’s disease: phytochemicals as neuroprotective agents
    Bharti Yadav, Prabhakar Gangwar, Kirti Kumari, Anuradha Yadav, Rashmi Rao, Keshav Kumar, Harkomal Verma, Monisha Dhiman, Anil Kumar Mantha · 2026 · Frontiers in Synaptic Neuroscience
  43. Restoration of mitochondrial dynamics and synaptic function by mitophagy enhancers in a tauopathy cell model
    Sudhir Kshirsagar, Arubala P. Reddy, P. Hemachandra Reddy · 2026 · Mitochondrion
  44. Alterations in diabetes mellitus gene expression in the development and progression of Alzheimer's disease: The PI3K/Akt pathway link
    Karla Aketzalli Hernández-Contreras, María Elena Hernández‐Aguilar, Deissy Herrera‐Covarrubias, Fausto Rojas-Durán, Gonzálo Emiliano Aranda-Abreu · 2021 · Revista de Fomento Social
  45. Impaired Redox Status and Age-Related Neurodegenerative Disorders
    Apoorv Sharma, Sandeep Singh, Geetika Garg, Abhishek Kumar Singh · 2021 · Healthy ageing and longevity
  46. Nanomedical drug delivery for neurodegenerative disease
    Navjot Kaur, Vanktesh Kumar, Thatikayala Mahender, Indrani Maji, Srushti Mahajan, Mayur Aalhate, Pankaj Kumar Singh, Sanjeev Kumar Sahu · 2022 · Elsevier eBooks
  47. Research progress on the role of PGC1α in mitochondrial dysfunction associated with Alzheimer’s disease
    Zhiqiang Li, Han-Sheng Lin, Xiao-Ping Huang, Shen-Qing Yu Zhang, Xiao Shu, Xinan Wu · 2023 · Ageing and Neurodegenerative Diseases
  48. Neuropsychiatric Symptoms are Related to Blood-biomarkers in Major Neurocognitive Disorders
    Inês Marques‐Aleixo, Arnaldina Sampaio, Lucimére Bohn, Flávia Borges‐Machado, Duarte Gabriel Moleiro Barros, Óscar Manuel Ribeiro, Joana Carvalho, José Magalhães · 2023 · Current Aging Science
  49. Glucose, glycolysis, and neurodegenerative disorders
    Patrícia Coelho, Ana Cristina Rego · 2023 · Elsevier eBooks
  50. TOMM40 and APOC1 variants differentiate the impacts of the APOE ε4 allele on Alzheimer's disease risk across sexes, ages, and ancestries
    Alexander M. Kulminski, Ethan Jain‐Washburn, Ian Philipp, Yury Loika, Elena Loiko, Irina V. Culminskaya · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  51. Joint and Individual Mitochondrial DNA Variation and Cognitive Outcomes in Black and White Older Adults
    Michelle C. Odden, Yongmei Li, Vasantha Jotwani et al. · 2024 · The Journals of Gerontology Series A
  52. Cognitive enhancement and anti-oxidant activities of Thespesia populnea L.: A bio-assay guided study using molecular docking for symptomatic alleviation of Alzheimer's disease
    Menna B. Abdel Halim, Ghada Farouk Metwally, Areeg Abd‐Elrazek, Ahmed Ali Al-Karmalawy, Haidy H. El-Zoheiry, Kadriya S. El Deeb, Hanaa H. Eid · 2024 · Scientific African
  53. Stress-related neurodegenerative diseases: Molecular mechanisms implicated in neurodegeneration and therapeutic strategies
    Maryam Azarfarin, Nasrollah Moradikor, Sara Salatin, Mehdi Sarailoo, Masoumeh Dadkhah · 2025 · Progress in brain research
  54. 7-α-O-Methylmorroniside ameliorated brain injury in 5×FAD mice by regulating the gut microbiome and NMDAR2B
    Fengxiao Hao, Mengnan Zeng, Bing Cao, Xiwen Liang, Zhi‐You Hao, Kaili Ye, Xinmian Jiao, Weisheng Feng, Xiaoke Zheng · 2025 · Frontiers in Pharmacology
  55. Alzheimer’s Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)
    Agueda A. Rostagno, Jorge A. Ghiso · 2025 · Antioxidants
  56. Perceived Alzheimer's Disease Threat as a Predictor of Behavior Change to Lower Disease Risk: The Gray Matters Study
    Christine J. Clark · 2016 · Digital Commons - USU (Utah State University)
  57. Glucose and Ketone Metabolism in the Aging Brain
    Stephen C. Cunnane, Alexandre Courchesne‐Loyer, Valérie St‐Pierre, Camille Vandenberghe, Étienne Croteau, Christian‐Alexandre Castellano · 2016 · Oxford University Press eBooks
  58. Anti-dementia Medications: Pharmacology and Biochemistry
    Anne Eckert, Amandine Grimm, Walter E. Müller · 2022 · Springer eBooks
  59. Amyloid Beta
    Abhinav Anand, Neha Sharma, Monica Gulati, Navneet Khurana · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  60. The role of mitochondrial dysfunction in Alzheimer’s disease
    N. N. Koberskaya · 2019 · Meditsinskiy sovet = Medical Council
  61. Over‐expression of N‐acetylaspartate synthase exacerbates pathological energetic deficit and accelerates cognitive decline in the 5xFAD mouse
    Jeremy S. Francis, Quy Nguyen, Vladimir Markov · 2024 · Journal of Neurochemistry
  62. Investigation of rs8106922 and rs157580 of TOMM40 Gene in In-dividuals with Late-Onset Alzheimer’s Disease in Iran
    Rana Hajilou, Dariush D Farhud, Marjan Zarif-Yeganeh · 2024 · Iranian Journal of Public Health
  63. Profiling of the Proteins Interacting with Amyloid Beta Peptides in Clinical Samples by PACTS-TPP
    Mengting Xu, Xiankun Wang, Yang Zhang, Nan Ji, Qianqian Wang, Ting Zhao, Congli Zhou, Chenxi Jia · 2024 · Journal of the American Society for Mass Spectrometry
  64. Nutraceuticals as an Intervention for Healthy Brain Ageing
    Puja Sah, Elangbam Tomtheelnganbee, Donkupar Syiem, Ramesh Sharma · 2024 · Healthy ageing and longevity
  65. A Drug Screening Targeting Upregulation of Syk Gene Identifies Neochlorogenic Acid and L‐Arabinitol Capable of Inducing the M2 Phenotype of Microglia in Alzheimer's Disease
    Difei Hu, Xianling Li, Yeyin Li, Qiushuang Zhang, Yicong Dai, Xucong Teng, Hongwei Hou, Jinghong Li · 2025 · ChemBioChem
  66. Gray matter structural and molecular signatures in Alzheimer's disease and late-life depression
    Shuo Yang, Xuemei Wang, Yan Yan, Jianbo Zhang, Yuyue Wei, Dai Zhang, Wenjun Yao · 2025 · Journal of Affective Disorders
  67. The role of IGF1 signaling in remote ischemic conditioning-mediated amelioration of Alzheimer's disease pathology and cerebral insulin resistance
    Jiayu Li, Wuxiang Sun, Sihan Guo, Jing Bai, Tao Yuan, Fujia Gao, Xin Zhang, Haoran Ma, Yuxuan Ma, Jiaxin An et al. · 2026 · Experimental Neurology
  68. Modulation of mitochondrial quality by exercise mimetics: A potential strategy for the prevention and treatment of Alzheimer's disease
    Zhiwei Ke, Bo Wang, Rongxiang Liang · 2026 · Journal of Alzheimer s Disease
  69. Overexpression of miR-455-3p enhances mitophagy, synaptic and mitochondrial proteins in Alzheimer’s disease
    Jangampalli Adi Pradeepkiran, Madhuri Bandaru, Md Ariful Islam, Sudhir Kshirsagar, Rainier Vladlen Alvir, Upasana Mukherjee, P. Hemachandra Reddy · 2026 · Mitochondrion
  70. MMP9 as a shared immune-related gene in Alzheimer’s and Huntington’s diseases: a cross-tissue transcriptomic analysis
    Xuepan Li, C L Zhang, Haisen Ni, Peng Sun, Jing Ren, Shan Huang · 2026 · Artificial Cells Nanomedicine and Biotechnology
  71. GV1001: repurposing a telomerase-derived peptide for neurological therapeutics
    Kyoungho Suk, Won-Ha Lee · 2026 · Expert Opinion on Investigational Drugs
  72. A multi-organ metabolomics atlas reveals molecular dysregulations in Alzheimer’s disease mouse models
    Simone Zuffa, Celeste Allaband, Vincent Charron‐Lamoureux, Andrés Mauricio Caraballo‐Rodríguez, Abubaker Patan, Ipsita Mohanty, Julius Agongo, John W. Bostick, T. Jaymie Connerly, Taren Thron et al. · 2026 · Cell Reports
  73. Nanotechnology-Enabled Therapeutics for Alzheimer’s Disease: Advances, Challenges, and Future Directions
    Pankaj Phullay, Rohil Panwar, Sahil Bajwa, Karan Wadhwa, Payal Chauhan, Rakesh Pahwa, Priyanka Kriplani, Harish Rajak, Rajendra Awasthi, Harish Dureja · 2026 · Regenerative Engineering and Translational Medicine
  74. Genetic Variation of MT-ND Genes in Frontotemporal Lobar Degeneration: Biochemical Phenotype-Genotype Correlation
    Rita Gaspar, Isabel J. Santana, Cândida Mendes, Ana Sofia Fernandes, Diana Duro, Marta Simões, Daniela Luís, Maria João Santos, Manuela M. Grazina · 2015 · Neurodegenerative Diseases
  75. Signaling pathway cross talk in Alzheimer's
    Juan Alejandro Godoy, Juvenal A. Ríos, Juan Manuel Zolezzi, Nady Braidy, Nibaldo C. Inestrosa · 2014
  76. Clinical Genetic Research 2: Genetic Epidemiology of Complex Phenotypes
    Darren D. O’Rielly, Proton Rahman · 2015 · Methods in molecular biology
  77. Small Molecule-Assisted PET: Approaches to Imaging of Conformational Diseases of the Brain
    Margit Pissarek · 2017 · World Journal of Neuroscience
  78. Chapter Six - Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
    Carlotta Giorgi, Saverio Marchi, Icm Simoes, Zhangpin Ren, Giampaolo Morciano, Mariasole Perrone, Paulina Patalas‐Krawczyk, Sabine Borchard, Paulina Jędrak, Karolina Pierzynowska et al. · 2018 · UCL Discovery (University College London)
  79. Pathophysiology and Management Approaches in Alzheimer’s Disease
    Shreshta Jain, Divya Goel, Sheikh Sana Nazir, Vaishali Yadav, Divya Vohora · 2023 · Springer eBooks
  80. Association of the Lipidome With Alzheimer's Disease and the Mediated Effect of Metabolites: A Two‐Step Mendelian Randomization Study
    Yunfeng Yu, Juan Deng, Xinyu Yang, Jingyi Wu, Rong Yu, Chenlu Guo · 2025 · Brain and Behavior
  81. Potential threat of environmental toxin palytoxin to cerebral nerves: A mechanism study in vitro and in vivo.
    Xue Zhang, Lei Huang, Yinliang Liu, Xuewen Li, Huan-Ying Zhou, Kang Qin, Shuang Li, Shu-Yue Ren, Xue-Xia Jia, Zhi-Xian Gao · 2025 · Ecotoxicology and Environmental Safety
  82. Mitochondria are an Important Target in the Search for new Drugs for the Treatment of Alzheimer′s Disease and Senile Dementia
    E. F. Shevtsova, Daria V. Vinogradova, Маргарита Е. Неганова, Pavel N. Shevtsov, B. V. Lednev, Сергей Олегович Бачурин · 2018 · Biomedical Chemistry Research and Methods
  83. C.11.02 The role of mitochondria in aging, MCI and dementia
    A Eckert · 2019 · European Neuropsychopharmacology
  84. Photobiomodulation: a novel approach to treating Alzheimer’s disease
    Lew Lim, Genane Loheswaran, Reza Zomorrodi, Anita E. Saltmarche, Linda L. Chao · 2019 · Elsevier eBooks
  85. Unraveling the Role of Mitochondria in Alzheimer’s Disease
    Sónia C. Correia, Paula Isabel Moreira, George L. Perry · 2020 · Oxford University Press eBooks
  86. Alternative stromal cell-based therapies for aging and regeneration
    Dikshita Deka, Alakesh Das, Meenu Bhatiya, Surajit Pathak, Antara Banerjee · 2021 · Elsevier eBooks
  87. Análise da influência dos hormônios sexuais na Doença de Alzheimer: revisão integrativa de literatura
    Bárbara Souza Fonseca, John Klysman Araujo, João Pedro Moraes Borges, Letícia Damasceno Janhaki Mota, Luíza Vitória Evangelista de Miranda, Tenylle Botelho Fernandes, Tereza Paula Pereira Santos, Sabrina Suellem Soares Barbosa, Mariane Costa Santos, Clarissa Leal Silva e Souza · 2021 · Revista Eletrônica Acervo Saúde
  88. Tocotrienols: Mother Nature’s Gift to the Brain
    Ahmad Farouk Musa, Cheang Jia Min, Christina Gertrude Yap · 2022 · Nutritional neurosciences
  89. Efeitos do consumo de castanha-do-brasil (Bertholetia excelsa H.B.K.) sobre o estresse oxidativo em pacientes com comprometimento cognitivo leve e a relação com variações em genes de selenoproteínas
    Bárbara Rita Cardoso · 2014
  90. Differential Brain Atrophy Patterns and Neurogenetic Profiles in Cognitively-Defined Alzheimer’s Disease Subgroups
    Colin Groot, Michel J. Grothe, Shubhabrata Mukherjee, Irina Jelistratova, Iris E. Jansen, Anna Catharina van Loenhoud, Shannon L. Risacher, Andrew J. Saykin, Christine L. Mac Donald, Jesse B Mez et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  91. A partial reduction of Drp1 enhances mitophagy, autophagy, mitochondrial biogenesis, dendritic spines and synaptic activity in a transgenic Tau mouse model of Alzheimer disease
    Ramesh J. L. Kandimalla, Maria Mańczak, Jangampalli Adi Pradeepkiran, P. Hemachandra Reddy · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: Mechanisms of light therapy for Alzheimer's disease
    Yurii V. Stepanov, Iuliia Golovynska, Renlong Zhang, Sergii Golovynskyi, L. I. Stepanova, Oleksandr I. Gorbach, Taisa Dovbynchuk, L. Garmanchuk, Tymish Y. Ohulchanskyy, Junle Qu · 2022 · Research Square
  93. The mtDNA-derived lncMtDloop promotes mitochondrial homeostasis maintenance and implications in AD
    Wandi Xiong, Kaiyu Xu, Jacquelyne Ka‐Li Sun, Siling Liu, Baizhen Zhao, Jie Shi, Karl Herrup, Hei‐Man Chow, Lin Lü, Jiali Li · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Increasing the vitamin C transporter SVCT2 in microglia improves synaptic plasticity and restrains memory impairments in Alzheimer’s disease models
    Camila Cabral Portugal, Evelyn Cristina da Silva Santos, Ana M. Pacheco, Sara Pinto, Tiago O. Almeida, Joana Tedim-Moreira, Dora Gavin, Teresa Canedo, Fabiana Sodré de Oliveira, Teresa Summavielle et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Mitochondrial Dynamics and Bioenergetics in iPSC-Derived Neurons with Familial Alzheimer’s Disease Mutations
    Courtney MacMullen, Neelam Sharma, Ronald L. Davis · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Multi-tissue proteomic signatures of Alzheimer’s disease: a systematic investigation in brain, CSF, blood and an exploratory study in tears
    Jie Shen, Yuhui Huang, Minyu Wu, Minqing Yan, Jing Sun, Hui Chen, Xin Xu, Peige Song, Pang Yao, Qian Xu et al. · 2025 · medRxiv
  97. Balanced deep learning on multi-omics networks identifies molecular subgroups of pathological brain aging
    Yacoub Abelard Njipouombe Nsangou, Maria A. Wörheide, Nicholas T. Seyfried, Jürgen Dönitz, Rima Kaddurah‐Daouk, Gabi Kastenmüller, Matthias Arnold · 2026 · medRxiv
  98. Dementia, Delirium, and Depression
    Heather S. Anderson · 2014 · Springer eBooks
  99. EFFECTS OF EXERCISE TRAINING ON BRAIN BIOENERGETICS: LACTATE AS A KEY MEDIATOR
    E Lezi · 2013 · KU ScholarWorks (University of Kansas)
  100. Frontiers in Clinical Drug Research - Alzheimer Disorders
    Marei, Hany E., Althani, Asmaa, Suhonen, Jaana, El Zowalaty, Mohamed E., Albanna, Mohammad A., Cenciarelli, Carlo, Wang, Tengfei, Caceci, Thomas · 2016 · BENTHAM SCIENCE PUBLISHERS eBooks